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To gain understanding of surveillance and epidemiology of
viral gastroenteritis outbreaks in Europe, we compiled data
from 10 surveillance systems in the Foodborne Viruses in
Europe network. Established surveillance systems found
Norovirus to be responsible for >85% (N=3,714) of all nonbac-
terial outbreaks of gastroenteritis reported from 1995 to 2000.
However, the absolute number and population-based rates of
viral gastroenteritis outbreaks differed markedly among Euro-
pean surveillance systems. A wide range of estimates of the
importance of foodborne transmission were also found. We
review these differences within the context of the sources of
outbreak surveillance information, clinical definitions, and struc-
tures of the outbreak surveillance systems.   
iral pathogens are the most common cause of gastroen-
teritis in industrialized countries (1,2). Mead et al. have
estimated that of the 38.6 million annual cases of gastroenteri-
tis in the United States, 30.8 million (80%) are the result of
viral infections (3). Enteric viral pathogens include Rotovirus
A, Astrovirus, adenovirus, and Sapovirus, but most viral gas-
troenteritis infections are caused by Norovirus (formerly Nor-
walk-like viruses) (1–3). The use of molecular diagnostics
including reverse-transcriptase polymerase chain reaction (RT-
PCR) and antigen detecting enzyme immunoassays (EIA) (4–
20) have changed researchers’ understanding of the epidemiol-
ogy of human Caliciviridae (including Norovirus and Sapovi-
rus) (21). For example, using RT-PCR assays, Pang et al.
showed that caliciviruses were as common a cause of infection
as rotaviruses among children <2 years of age (22). 
In addition, many reports have established the importance
of noroviruses as a cause of outbreaks of food- and waterborne
illness (23–28), though estimates of the proportion of infection
spread by these modes vary widely: from 14% in England and
Wales (29) to <40% in the United States (7). While person-to-
person transmission is probably the mode of infection of most
cases, food- and waterborne infections may be of particular
importance since these outbreaks have the potential to involve
large numbers of people and wide geographic areas and, per-
haps, to introduce new variants to an area (30).
A research network to study foodborne viruses in Europe
was recently funded by the European Union. Through this
project, the participant institutes have networked their viro-
logic and epidemiologic surveillance in order to detect tran-
snational outbreaks, elucidate transmission routes, and make
international comparisons of the epidemiology of viral gastro-
enteritis. We chose to study outbreaks rather than community
cases because viral gastroenteritis is a very common infection
(1); therefore, enumeration of epidemics (or outbreaks) may be
more practical and useful since individual cases are poorly
reported (31). International comparisons of surveillance data
are difficult because criteria for effective surveillance custom-
arily varies across borders (32). 
The objective of this survey was to capture information on
the structure of outbreak surveillance in each country (includ-
ing sources of data and definitions employed) and to gain esti-
mates of the frequency of outbreaks, as well as to compare the
setting of outbreaks, the importance of foodborne transmis-
sion, and the use of characterization techniques. We present
surveillance data from viral gastroenteritis outbreaks from
1995 to 2000 collected by participant European countries.
These data provide baseline information for future harmoniza-
tion and comparison efforts.
Methods
A questionnaire was sent by e-mail to the project leaders of
the 13 participant institutions (from 10 countries) in the Food-
borne Viruses in Europe group. The questionnaire, adminis-
tered in English, was developed and completed in
collaboration with research and medical virologists and epide-
miologists working in viral gastroenteritis surveillance. Gen-
eral information on surveillance systems (including sources of
data, estimate of national population under surveillance, defi-
nition of a viral gastroenteritis outbreak, and number of such
outbreaks investigated) was collected for the period 1995–
2000. More detailed epidemiologic data (setting, mode of
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transmission, and implicated food vehicles) were collected
from outbreaks that occurred in 2000. Contributors were sent a
summary report and asked to confirm that the data presented
accurately represented their surveillance.
Results
Data Sources of Surveillance Systems
One completed survey questionnaire was received from all
10 countries. A range of sources contributed data on viral gas-
troenteritis outbreaks for European surveillance systems
(Table 1), including diagnostic reference laboratories, local
public health staff, food inspectorates, and physicians. We
derive our data from routine surveillance except for Germany,
where systematic national surveillance was not operational
during the survey period. German data were collected from
laboratories that performed RT-PCR diagnostics in the sur-
veyed period. The same applies to the Netherlands, Finland,
and Sweden, although the collaborating centers in these coun-
tries run the sole reference laboratory service.
Outbreak Definition and Geographic 
Coverage of Surveillance Systems
All surveillance systems reported data collected on out-
breaks from the whole population of their respective countries
except for Italy, where a small geographically convenient sam-
ple of approximately 1% of the population was covered by sur-
veillance (Table 2). Both the criteria and the use of outbreak
definitions differed among the surveillance systems (Table 2).
Some systems collected information only on incidents that met
a specific definition; other systems collected information on
all incidents and then applied definitions retrospectively for
analysis. Some surveillance systems required laboratory con-
firmation to attribute an outbreak to an enteric viral pathogen.
Among systems requiring laboratory confirmation, a range of
stringency existed from at least one positive sample (England
and Wales) to half of all stools positive for virus (Finland and
the Netherlands). 
Outbreaks Investigated
Outbreak reports were available from the entire surveyed
period (1995–2000) from a few countries: England and Wales,
Slovenia, Spain, the Netherlands, and Sweden. The overall
numbers of outbreaks investigated ranged from 2 in Italy to
1,643 in England and Wales (Table 3).
National outbreak reporting rates for each country were
calculated by dividing annual outbreaks by national population
(Figure 1). Rates in Sweden (9–22 outbreaks/million in popu-
lation) were markedly higher than in any other country. In
most countries, approximately 3–7 outbreaks per million pop-
ulation were ascertained annually. Since 1997, outbreak
reporting rates have been increasing in most countries. 
Completeness of Basic Epidemiologic Data
Participants were asked how many of the outbreaks reports
from the year 2000 included  details on first date of onset, last
date of onset, number of persons ill, number of persons hospi-
talized, number of related deaths, and setting of the outbreak.
Completeness of these data differed substantially between
countries: none of the data were available from Sweden,
whereas data were almost 100% complete for all categories in
England and Wales, Denmark, and Slovenia (Figure 2).
Setting of Outbreaks
The settings where reported outbreaks occurred differed
substantially by country (Figure 3). In England and Wales,
Spain, and the Netherlands, most reported outbreaks occurred
in hospitals and residential homes (78%, 64%, and 66%,
Table 1. Sources of information of viral gastroenteritis surveillance systems in the Foodborne Viruses in Europe network
 Country
Sources of outbreak data
Type of outbreaks 
reported
Diagnostic microbiology 
laboratory
Food safety 
inspectorate
Physician/ patient 
reports
Local/regional 
public health authority
Denmark Yes Yes Yes Food/waterborne
France Yes Yes Food/waterborne
England and Wales Yes All
Italy Yes All
Finland Yesa All
Sweden Yes All
Germany Yes Yesb All
Slovenia Yes Yes All
Spain Yes Yes All
the Netherlandsc Yes Yes Yes Yes Alld
aParticipant is sole laboratory performing viral testing, and coordination is conducted at National Public Health Laboratory and National Food Administration. 
bNorovirus became a reported disease in January 2000. From 1997 to 2000, reports from local health departments were collected unsystematically.
cDutch national data were collected from three systems: notification system, food safety inspectorate, and laboratory-based system (from diagnostic microbiology laboratories, local/
regional public health authorities, physician/patient reports, and other institutions in which outbreaks occurred).
dFoodborne only for systems 1 and 2.RESEARCH
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respectively), whereas in Denmark, 13 (76%) of 17 reported
outbreaks occurred in food outlets. In Denmark, surveillance is
done by the Food Safety Inspectorate, which collects reports
of suspected foodborne outbreaks only. The Inspectorate is not
informed of person-to-person spread outbreaks, which are
more commonly seen in residential institutions and hospitals.
In Slovenia, the majority of reported outbreaks occurred in
day-care centers (10/14; 71%), and in France, most reported
outbreaks occurred in private houses (7/9; 78%). In France,
reporting was recommended only for large outbreaks or if oys-
ters, an item commonly consumed in French households, were
the suspected vehicle of infection.
Food and Water as Sources of Outbreaks
Among countries conducting broad-based outbreak sur-
veillance, the following proportions of viral gastroenteritis
outbreaks were reported to be associated with food- or water-
borne transmission: Finland (24%), the Netherlands (17%),
Slovenia (14%), Spain (7%), and England and Wales (7%)
(Table 4). Very rarely was laboratory evidence (detection of
the same organism in the vehicle and stool specimens) or sta-
tistical evidence (case-control or cohort) available that demon-
strated the association of the vehicle with illness. During the
survey period, Danish and French surveillance almost exclu-
sively focused on outbreaks transmitted through food and
water. Therefore, estimates of the proportion of food and water
Table 2. National coverage and use of clinical definitions for viral gastroenteritis by European surveillance systems 
Country National coverage %a
Definition of viral 
gastroenteritis outbreakb
Laboratory 
confirmation required
Outbreak definition applied
As entry criteria in database Retrospectively for analysis
Denmark 100 Kaplan’s, shellfish Always Always
England and Wales 100 General Yes Always Never
Finland 100 Clinical Yes Always Never
France 100 Clinical, shellfish Always Never
Germany
Italy 1 Clinical Always Always
Slovenia 100 Clinical Sometimes Sometimes
Spain 100 General Yes Always Sometimes
Sweden 100 Kaplan’s, clinical Yes Always Sometimes
Netherlands  100 System 1: clinical
System 2: Kaplan’s
System 3: clinical
Yes
Yes
Sometimes Always
aRefers to geographic coverage by surveillance, not completeness of reporting.  
bKaplan’s criteria for recognition of Norovirus outbreaks (33); clinical, clinical criteria (different from Kaplan’s) specifying that cases must be clustered in time and place; general, gen-
eral definition used for all outbreaks of gastroenteritis with laboratory confirmation required to attribute outbreak to viral pathogen; shellfish, specific criteria used for identifying shell-
fish outbreaks.
Table 3. Reported outbreaks of viral gastroenteritis, European surveillance, 1995–2000
2000 Total
1995 1996 1997 1998 1999 All viral organisms Rotavirusa Norovirusa 1995–2000
Denmark 9 11 17 0 17 (100) 37
England and Wales 392 352 151 219 239 290 13 (4) 273 (96) 1,643
Finland 5 27 35 58 1 (2) 56 (97) 125
France 4 9 7 8 19 28 1 (14)b 5  (71)b 43
Germany 1 53 145 227 0 227(100) 426
Italy 0 0 0 0 0 2 0 2 (100) 2
Slovenia 8 6 8 4 5 14 8 (57) 6 (43) 45
S p a i n 3 7 2 42 52 96 6 5 5 6  ( 4 3 ) c 8 (57)c 236
Sweden 81 130 130 130d 190d 195d 190 (97) 856
the Netherlands 25 69 54 36 58 59 5 (13)e 32 (84)e 301
aNumber of outbreaks attributed to organism (percentage of year 2000 outbreaks).
bBased on seven laboratory-confirmed viral outbreaks.
cBased on 14 laboratory-confirmed viral outbreaks. 
dApproximate figures.
eBased on 38 laboratory-confirmed viral outbreaks.Emerging Infectious Diseases  •  Vol. 9, No. 1, January 2003 93
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transmission from these countries cannot be compared to the
general estimates in other countries.
Molecular Characterization Techniques
Different molecular techniques were used by participating
institutes to characterize virus from outbreaks in 2000.
Reverse line blot was used in the Netherlands and Spain, and
the heteroduplex mobility assay was used in England and
Wales. Sequence analysis was performed in England and
Wales, Finland, France, Italy, Germany, Spain, and the Nether-
lands; EIA were used in England and Wales, and a microplate
hybridization technique was used in Finland.   
Discussion
Viral gastroenteritis infection, typically a self-limiting con-
dition of short duration in humans, is extremely common and
associated with relatively few deaths. Surveillance of out-
breaks of this infection, rather than individual cases, may be
more appropriate. In our review of the surveillance for this
infection in Europe, we found variations in the organizations
conducting surveillance, the surveillance definition of a viral
gastroenteritis outbreak, the populations under surveillance,
and the completeness of descriptive and analytical epidemio-
logic and diagnostic information.
Researchers comparing surveillance information at an
international level should consider the outputs of surveillance,
as well as the influence of methodology and structure of sur-
veillance on these outputs. Surveillance for viral gastroenteri-
tis in Europe is poorly developed; systems vary in their
sources of data, definitions, and use of diagnostic techniques.
These differences are reflected in the wide range of numbers
of outbreaks, population-based rates, and epidemiologic pat-
terns observed across Europe. Nonetheless, our comparison of
this surveillance data was an informative exercise because
international epidemiologic databases of viral gastroenteritis
infections have not been developed. In many of the countries
included in the Foodborne Viruses in Europe network, viral
gastroenteritis has not been considered a priority, and these
countries do not have a well-developed surveillance system.
This inventory of surveillance data will aid in the development
of a more consistent and complete surveillance across Europe.    
These data clearly show that both the absolute number and
the population-based rates of viral gastroenteritis outbreaks
differ substantially between European surveillance systems.
From 1995 to 2000, 1,643 outbreaks of viral gastroenteritis
were investigated by the Public Health Laboratory Service in
England and Wales, but the outbreak rates (number of out-
breaks/population) were highest in Sweden for every surveyed
year. Some variation in these figures occurred because a num-
ber of the surveillance systems required laboratory confirma-
tion while others did not (Table 2). However, the criteria
suggested by Kaplan et al. to recognize an outbreak of viral
etiology is widely used and is generally accepted as an effec-
tive clinical tool in the absence of diagnostic information (33).
Interestingly, surveillance systems with the most stringent out-
break criteria, including laboratory confirmation of outbreaks
(England and Wales, Finland, and Sweden) ascertained the
most outbreaks, likely because surveillance in these countries
is more developed and integrated better with reporting bodies. 
However, even the surveillance systems with the highest
figures greatly underascertain viral gastroenteritis. A study of
infectious intestinal disease in England and Wales estimated
that only 1/300–1,500 cases of Norovirus gastroenteritis are
reported to national surveillance (34). For a case to be ascer-
Figure 1. Viral gastroenteritis outbreak rates, European surveillance,
1995–2000. Rates based on year 2000 national population estimates.
Figure 2. Completeness of epidemiologic and viral charac-
terization information on viral gastroenteritis outbreaks,
European surveillance, 2000. SE, Sweden; FI, Finland; SI,
Slovenia; E&W, England and Wales; NL, the Netherlands;
DK, Denmark; DE, Germany; ES, Spain; FR, France; IT,
Italy. *Approximately 500 outbreaks strains were character-
ized in the United Kingdom, but typing is not linked to epide-
miologic data. RESEARCH
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tained by national surveillance, patients must be examined by
their primary-care doctor, a specimen must be taken and sub-
mitted for laboratory testing, the test must be positive (the
amount of false negatives will depend on the diagnostic tech-
nique), and the surveillance unit must be notified. Ascertaining
outbreaks requires an additional step in which investigators
must recognize epidemiologic links between cases. While this
chain of events will differ from country to country, the princi-
ple of underascertainment affects all surveillance. However,
outbreak recognition and investigation will, through case find-
ing, lead to better ascertainment of persons affected in out-
breaks.   
Although most surveillance systems may be designed for
national coverage, reports were incomplete to a varying
degree. Ascertained outbreaks varied geographically and were
incomplete, as demonstrated by the large variation in reported
outbreaks (Table 3). 
This survey found that the great majority of European viral
outbreaks could be attributed to Norovirus. In Denmark,
England and Wales, Finland, France, and Sweden, >95% of
nonbacterial outbreaks were attributed to noroviruses as were
84% of outbreaks in the Netherlands. The relative number of
infections from noroviruses was lower in Slovenia (43%) and
Spain (57%), although these estimates are based on a small
number of outbreaks (n=14 for both). These figures are consis-
tent with previous reports that Norovirus could be detected in
91% of all nonbacterial infectious intestinal disease outbreaks
in the Netherlands (9) and 89% of such outbreaks in Sweden
(35). Similarly, Fankhauser et al. found Norovirus responsible
for 96% of nonbacterial outbreaks in the United States (7).  
Estimates of the importance of foodborne transmission
also varied widely in this survey. Foods were implicated as the
vehicle of transmission in 16 (94%) of 17 outbreaks in Den-
mark and 28 (100%) of 28 outbreaks in France because sur-
veillance systems in these countries were designed to detect
foodborne disease. In countries with more general outbreak
data, estimates of foodborne transmission were lower: 7 (17%)
of 41 in the Netherlands, 14 (24%) of 58 in Finland, and 20
(7%) of 290 in England and Wales, although laboratory and
statistical evidence of association with food or water was
scant. 
The settings of outbreaks also reflected the proportion of
reported outbreaks that were ascertained to be foodborne. For
example, in Denmark, 75% of all reported outbreaks were set
in food outlets. In Spain, the Netherlands, and England and
Wales, most reported outbreaks occurred in residential homes
and hospitals, with only a small fraction occurring in food out-
lets.  
In Finland, the National Public Health Laboratory is the
only facility in the country testing for Norovirus and, there-
fore, is aware of all such investigations. Most other surveil-
Figure 3. Setting of viral gastroenteritis outbreaks, European surveil-
lance, 2000. SE, Sweden; FI, Finland; SI, Slovenia; E&W, England and
Wales; NL, the Netherlands; DK, Denmark; DE, Germany; ES, Spain;
FR, France; IT, Italy. *Includes restaurants, cafes, public bars, mobile
vendors, canteens, and catered events.
Table 4. Foodborne transmission and supporting evidence of implicated food vehicles, European surveillance, 2000 
Evidence
Country Total outbreaks Food/waterborne outbreaks (%) Laboratorya Statisticalb
Denmark 17 16 (94) 1 0
England and Wales 290 20 (7) 1 4
Finland 58 14 (24) 0 0
France 28 28 (100) 2 1
Germany 227
Italy 2 0
Slovenia 14 2 (14) 0 0
Spain 14 1 (7) 0 1
Sweden 190
the Netherlands 41 7 (17) 0 2
aSame organism found in stool specimen and food vehicle.
bStatistically significant result from cohort or case-control study.Emerging Infectious Diseases  •  Vol. 9, No. 1, January 2003 95
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lance systems receive data on outbreaks from a number of
sources including local public health authorities, other diag-
nostic laboratories, and physicians. Surveillance in Denmark is
anomalous in that only outbreaks from the national food
inspection service are reported, which, in conjunction with the
special mention of shellfish in the definition of an outbreak,
explains the preponderance of food-related outbreaks in Dan-
ish surveillance. Such diversity in data sources and definitions
may also explain the differences in estimates among other
countries, including those external to the Foodborne Viruses in
Europe network. Based on data from 90 outbreaks, Fankhauser
et al. estimated that 47% of Norovirus outbreaks in the United
States were spread by food (7). This estimate, derived from
local and state health department reports, may be affected by
reporting bias or may truly reflect different epidemiologic pat-
terns of viral gastroenteritis outbreaks compared to those seen
in European countries. Factors that might affect the relative
amount of foodborne transmission of Norovirus are the viro-
logic quality of food, food-handling guidelines, and infection
control practice in health-care settings (36).
DNA sequencing of PCR amplicons, used to characterize
outbreak strains by laboratories in England and Wales, Fin-
land, France, Italy, Germany, Spain, and the Netherlands,
yields the most virologic information, although this technique
is a labor-intensive procedure. The heteroduplex mobility
assay (37), as well as an EIA based on one of the Norovirus
genotypes (Grimsby virus), was used by the laboratory in
England and Wales. Reverse line blot (38) was used in the
Netherlands and Spain in 2000 and has since been adopted by
a number of the other collaborating institutes to characterize
Norovirus. The use of the heteroduplex mobility assay (37),
reverse line blot (38), and sequencing to characterize virus has
demonstrated the considerable and dynamic genetic diversity
of human Caliciviridae (39). The use of such techniques by a
wider group may demonstrate important differences in molec-
ular epidemiology between countries and may detect the intro-
duction of a novel strain to an area (40) by tracking and linking
outbreaks over wide geographic areas. 
In the retrospective survey presented here, determining
whether differences in frequency, setting, and importance of
foodborne transmission are real or artifacts caused by interna-
tional variation in surveillance system design was difficult.
Timely collection of information for case-control or cohort
studies and development of tests for virus detection in food are
needed to advance understanding of the extent of foodborne
transmission of Norovirus. Success of the Foodborne Viruses
in Europe network will depend on the ability to compare both
virologic and epidemiologic data. Protocols for harmonizing
the characterization of noroviruses and an outbreak question-
naire with a minimum dataset have been defined. While data
collection will be harmonized, information will be obtained
from an international group whose range of perspectives will
yield different interpretations of epidemiologic events. The
timely feedback of surveillance data to participants is an
essential step in the cycle of continued improvement of a sur-
veillance system (41) that we have made possible through this
European Union–funded network. In addition to describing the
current state of viral gastroenteritis surveillance in Europe, this
report will act as a baseline to interpret prospective outcomes
of the Foodborne Viruses in Europe network. 
Foodborne Viruses in Europe is funded by the European
Commission, Directorate General Research under the Quality
of Life and Management of Living Resources- QLK1-CT-
1999-00594.  
Mr. Lopman is an epidemiologist at the Gastrointestinal Diseases
Division of the Public Health Laboratory Communicable Disease
Surveillance Centre. He coordinates the epidemiologic surveillance
for the Foodborne Viruses in Europe consortium.  
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